Pharmaceuticals

Global Jynneos Market Report 2026–2035: Key Forecasts and Growth Areas

March 5, 2026March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the jynneos market from 2026–2035 with trusted insights from The Business Research Company

How is the Jynneos Market size predicted to change over the forecast window of 2026–2035?

Historical growth can be ascribed to a combination of factors, including worldwide smallpox eradication endeavors, previous monkeypox occurrences, the creation of more secure vaccinia platforms, governmental readiness initiatives, and public health immunization drives.

The expansion anticipated in the upcoming period is attributable to several factors, including the increasing risks associated with zoonotic diseases, the enlargement of national vaccine reserves, a rise in financial support for biodefense, enhancements in global surveillance systems, and the broadening reach of adult immunization programs.

Significant trends projected for the forecast timeframe involve an escalating emphasis on preventing emerging infectious diseases, the proliferation of non-replicating vaccine technologies, an increase in government-led immunization initiatives, the accumulation of strategic vaccines, and a growing understanding of zoonotic ailments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20118&type=smp

Which Drivers Are Contributing To The Expansion Of The Jynneos Market?

The rising incidence of monkeypox cases is projected to stimulate growth in the jynneos market. Monkeypox, a viral illness caused by the monkeypox virus within the orthopoxvirus family, is experiencing an increase in cases primarily due to heightened global travel and greater human-wildlife interaction, which facilitates the rapid spread of infectious agents beyond isolated outbreaks. Jynneos offers a significant advantage for monkeypox prevention because it effectively protects at-risk individuals and presents a safer option for those with compromised immune systems compared to conventional smallpox vaccines. For example, data from the European Centre for Disease Prevention and Control, a Europe-based government agency, indicated that between January 2022 and July 2024, over 100,000 confirmed cases of pox caused by monkeypox virus (MPXV) clade I and clade II, including over 200 deaths, were reported by more than 120 countries globally, highlighting the escalating public health concern. Consequently, the increasing number of monkeypox infections is a primary catalyst driving the expansion of the Jynneos market. This market expansion is further advanced by the development of combined vaccines aimed at enhancing public health preparedness, a central focus for companies operating in the jynneos market. Combined vaccines are immunizations that protect against multiple diseases with a single shot, thereby reducing the number of injections needed for full immunity. A notable example occurred in August 2024, when Bavarian Nordic A/S, a Denmark-based biotechnology company, announced that Singapore’s Health Sciences Authority (HSA) had approved JYNNEOS (MVA-BN) for the prevention of smallpox and pox in adults aged 18 and older considered at high risk for these infections. JYNNEOS (MVA-BN) is designed as a non-replicating vaccine to provide a safer alternative, particularly for immunocompromised individuals, and was developed with the objective of improving public health readiness and addressing emerging infectious diseases.

What Segment Categories Are Covered In The Jynneos Market?

The jynneos market covered in this report is segmented –

1) By Indication: Prevention of Monkeypox, Prevention of Smallpox

2) By Formulation: Injectable Formulation, Lyophilized Powder for Reconstitution

3) By Patient Demographics: Adult Patients, Pediatric Patients, High-Risk Populations

4) By Distribution channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Specialty Clinics, Public Health Organizations, Home Healthcare Providers

Which Major Industry Participants Are Leading The Jynneos Market Growth?

Major companies operating in the jynneos market are Bavarian Nordic A/S

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/jynneos-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Jynneos Market?

North America was the largest region in the jynneos market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the jynneos market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Jynneos Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20118&type=smp

Browse Through More Reports Similar to the Global Jynneos Market 2026, By The Business Research Company

Market Research Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/market-research-services-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Varenicline Market Report 2026

https://www.thebusinessresearchcompany.com/report/varenicline-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795